Search

‘Want an upgrade?’ Moral distress in audiology

Ethical practice in audiology has become a hot topic in recent years, particularly in the independent sector where sales can be linked to commissions. Andrea Simpson has explored this issue in her research and shares her insight into the drivers...

Addressing the hearing needs of people with dementia

Dr Dawes provides a comprehensive overview of hearing needs of persons with dementia coupled with recommended guidelines for hearing-related considerations when assessing and intervening with persons with dementia. With ageing populations, we face a global dementia challenge. Rates of both...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Tish Gaffney – AAA President

From a sunny Southend, UK, Gareth Smith takes 10 minutes to dial into the Sunshine State, USA, and catch up with Tish Gaffney for a lightning-speed chat on the movements and motivations of the 35th president of the American Academy...

A tribute to Mead C Killion, PhD 1939-2025

The renowned audiologist and inventor Mead Killion passed away comfortably on 3 November 2025 in Elkhorn, Wisconsin, US. Mead was known for inventing products that left us scratching our heads, trying to figure out why we hadn’t thought of them...

How can we be SMART with virtual consultations?

At the beginning of 2020, video conferencing and phone consultations accounted for less than 1% of all consultations. Now it is probably 70%. Whilst there are many remote consultation solutions available, Tina Marshall describes what the ideal solution should look...

Ossicular reconstruction

Ossicular reconstruction often yields disappointing results, even for the most experienced and skilled of otologists. John Dornhoffer and David Walker explain that the most important determinant of outcome is the patient’s middle ear environment, and offer some valuable words of...

The doctor – pharmaceutical company relationship

‘Which drug rep is taking us out tonight?’ We have heard this phrase uttered at conferences since meetings began, but as Dylan said ‘those times they are a changing’ thanks to the Association of the British Pharmaceutical Industry (ABPI) and...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

Decreased sound tolerance in autism: understanding and distinguishing between hyperacusis, misophonia, and phonophobia

Decreased sound tolerance (DST) affects a significant proportion of autistic people throughout their lifetime and, as Zachary J Williams explains, it is important that clinicians are aware of the three distinct subtypes of DST when making a diagnosis. Autism spectrum...